Can the protocol be signed electronically?

Yes. Electronic signatures are generally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure the platform provides an audit trail and, for PHI, a HIPAA Business Associate Agreement.

Is notarization required for the protocol?

Not typically for operational protocols, but certain attestations or accompanying affidavits may require notarization depending on state rules; confirm with counsel.

How long must records be retained?

Retain protocol records per the longest applicable rule: HIPAA requires 6 years, IRS rules often require 3 years, and some state rules may extend retention.

What authentication should signers use?

Use at minimum email-based authentication; consider SSO or two-factor methods for privileged signers and to strengthen attribution.

Does electronic storage meet DEA requirements?

DEA accepts electronic records when they meet integrity and retrievability rules; ensure tamper-evident storage and complete audit logs.

Who to contact after suspected diversion?

Follow internal incident procedures, notify compliance leadership, and report to appropriate state agencies and law enforcement as required by state law.

Electronic Signature
Templates
Healthcare
Healthcare Controlled Substances Protocol

Healthcare Controlled Substances Protocol

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CONTROLLED SUBSTANCES PROTOCOL

Facility Identification

Facility Name Facility Address

Effective Date:

Purpose and Scope

This protocol establishes legally and professionally required procedures for the prescribing, dispensing, storage, inventory, monitoring, and disposal of controlled substances within the facility. It applies to all licensed prescribers, pharmacists, nursing staff, and designated custodians engaged in handling controlled substances in inpatient and outpatient settings. Scope includes Schedule II through V controlled substances and any state-designated controlled medications.

Definitions

For purposes of this protocol: "Authorized Prescriber" means an individual licensed to prescribe controlled substances in accordance with state and federal law. "Custodian" means the individual(s) designated to maintain secure storage and inventory. "Diversion" means any unauthorized taking, use, or distribution of controlled substances.

Authorized Personnel and Roles

Authorized personnel must be documented and current. Prescribers must maintain active licensure and DEA (or state equivalent) registration. Custodian(s) are responsible for secure storage, inventory reconciliation, and reporting loss or theft.

List Authorized Prescribers and Roles (name, license, role)

Controlled Substance Schedules Covered

The protocol governs handling of the following schedules (check all that apply) and any additional state-designated lists.

Schedule II Schedule III Schedule IV Schedule V

Prescribing and Ordering Procedures

Prescriptions and orders must include patient identifiers, diagnosis, dosage, quantity, directions, prescriber name and license, and applicable dates. Electronic prescribing of controlled substances is required where technology and law allow. All orders must comply with state and federal requirements and facility medical policy.

Patient Name Patient Date of Birth Medical Record Number Medication / Controlled Substance

Dosage:

Quantity:

Refills:

Directions for Use

Start Date:

End / Review Date:

Documentation and Medical Record Requirements

All prescribing events, dispensing entries, monitoring results, and patient agreements must be entered in the medical record contemporaneously. Documentation shall include clinical indication, informed consent when applicable, risk assessment, prescription details, and follow-up plan. Records shall be retained consistent with facility retention policy.

Monitoring Plan (UDS, pill counts, follow-up frequency)

Inventory, Storage, and Security

Controlled substances must be stored in locked, substantially constructed containers or automated dispensing systems with access limited to authorized personnel. Access logs must be maintained and periodically reviewed. Loss, theft, or unexplained discrepancies require immediate notification to the designated custodian and facility leadership.

Storage Location and Security Measures Inventory Reconciliation Frequency

Wastage, Return, and Disposal

Wastage and disposal of controlled substances must be witnessed, documented, and disposed in accordance with applicable regulatory requirements. Returns to pharmacy and destruction events must be recorded and reconciled.

Disposal Procedure and Witness Requirements

Diversion Prevention and Incident Reporting

Suspected diversion, loss, or theft must be reported immediately to the designated custodian and institutional compliance officer. An internal investigation will commence and appropriate regulatory notifications will be made as required by law. Disciplinary action up to termination and referral to licensing authorities may result from confirmed diversion.

Incident Reporting Contact

Training, Competency, and Auditing

All authorized personnel shall complete initial and periodic training on prescribing standards, diversion prevention, secure handling, and documentation. The facility will conduct routine audits to ensure compliance; audit findings must be remediated within prescribed timelines.

Training Requirements and Record Location Audit Frequency

Patient Education and Informed Consent

Patients receiving controlled substances must be counseled on risks, safe storage, potential for dependence, signs of overdose, and proper disposal. The provider must document that education occurred and that the patient was advised of alternatives and monitoring requirements.

Patient education provided and documented Education Topics Documented

Legal Compliance and Reporting

This protocol requires compliance with applicable federal and state controlled substance statutes and regulations. Prescribers and facility personnel must cooperate fully with lawful inspections, audits, and reporting obligations. Noncompliance may result in corrective action and notification to licensing or regulatory bodies.

Record Retention Period

Audits, Sanctions and Protocol Amendments

The facility will audit compliance with this protocol. Findings will be documented, and corrective action plans required. Amendments to this protocol require approval by the Medical Director and designee indicated below. All personnel will be notified of substantive changes.

Protocol Amendment Notes

Certification

By signing below, the signatories certify that this protocol accurately reflects facility policy for controlled substances, that they have authority to implement and enforce the protocol within the facility, and that they will ensure adherence to applicable controlled substances statutes, rules, and standards of professional practice.

Medical Director:

By:

Date:

Controlled Substances Custodian:

By:

Date:

What the Healthcare Controlled Substances Protocol Is

The Healthcare Controlled Substances Protocol is a formal clinical and administrative document that defines how a healthcare organization manages prescribing, dispensing, storage, inventory, and documentation for controlled substances. It consolidates regulatory obligations, prescriber and staff responsibilities, recordkeeping formats, authentication and audit procedures, and incident response steps to reduce diversion, ensure patient safety, and maintain compliance with federal and state law.

Why a Clear Protocol Matters for Patient Safety and Compliance

A written protocol establishes consistent practices that reduce diversion risk, supports HIPAA-protected handling of patient records, documents chain-of-custody for controlled drugs, and creates an auditable trail for regulators and internal review.

Who Typically Prepares and Follows This Protocol

The protocol should be reviewed and signed by authorized personnel and maintained with secure access controls to ensure traceability and accountability.

Pharmacy Directors and Pharmacists responsible for procurement, inventory controls, and reconciliation.
Medical Directors and Prescribers who authorize controlled substance use and oversee clinical protocols.
Compliance Officers and Risk Managers who audit records, report discrepancies, and manage regulatory communication.

Who Signs and Approves the Protocol

Medical Director

The Medical Director signs to confirm clinical oversight and delegation of prescribing privileges. Their signature documents approval of clinical safeguards and prescribing limits.

Pharmacy Director

The Pharmacy Director signs to accept responsibility for storage, inventory control, recordkeeping, and dispensing procedures under the facility's controlled substances program.

Step-by-Step: Completing the Protocol

Follow these sequential steps to draft, approve, and publish a compliant protocol within your organization.

01

Draft Responsibilities: List clinical, pharmacy, and administrative duties clearly.
02

Inventory Controls: Define secure storage, access logs, and reconciliation schedules.
03

Prescribing Rules: State prescriber authorization, dosing limits, and justification requirements.
04

Approval and Signatures: Obtain signatures from Medical and Pharmacy Directors and compliance lead.

Typical Workflow for Protocol Implementation

A standard operational flow turns the written protocol into everyday practice through defined handoffs and documentation steps.

Publish: Distribute final protocol to departments and post controlled access copy.
Train: Deliver role-specific training and document completion.
Operate: Follow daily procedures for prescribing, dispensing, and storage.
Audit: Run periodic reconciliations and incident reviews; update protocol as needed.

Configuring an Electronic Protocol Workflow

Set up a digital workflow that enforces role-based fields, audit capture, and secure storage to match your written protocol.

Field	Configuration
Signer Order	Sequential: Medical Director → Pharmacy Director → Compliance
Authentication	Email + optional SMS code or organization SSO
Audit Capture	Include timestamps, IP, and certificate of completion
Retention	Automatic export to secure archive with access controls

Technical Considerations for eSubmission and Signing

Ensure the selected solution can provide audit trails, optional advanced signer authentication, and a Business Associate Agreement when handling PHI.

Integrations: Salesforce, Microsoft 365, NetSuite, Google Workspace, Box, Procore supported
File Formats: PDF, DOCX, and HTML accepted for upload and export
Compliance: HIPAA BAA support; TLS and AES-256 encryption

Essential Data Elements to Record

Patient Name: Full legal name required

Date of Service: MM/DD/YYYY format

Prescriber ID: DEA and state license

Medication Detail: Drug, strength, quantity

Dispensing Unit: Pharmacy name/location

Audit Trail: Timestamp and signer attribution

Common Pitfalls to Avoid

Missing DEA or license numbers that block valid prescribing
Using informal initials instead of full signatures, complicating audits
Failing to document inventory reconciliations on schedule
Not obtaining a HIPAA BAA when storing PHI with a vendor

Regulatory Risks and Potential Penalties

DEA Action: Administrative sanctions or license suspension

Civil Penalties: Fines under state controlled substances laws

Criminal Liability: Felony charges for distribution/diversion

Malpractice Exposure: Professional liability claims

Contractual Breach: Loss of third-party payer agreements

HIPAA Violations: Civil fines and corrective action

Key Timing Requirements and Typical Deadlines

Certain actions and records have statutory retention or reporting deadlines; missing them can trigger penalties or audit findings.

Policy Review Frequency:

Annual review recommended

Inventory Reconciliation:

Daily or shift-based counts per facility policy

Incident Reporting:

Report suspected diversion promptly per state rules

HIPAA Record Retention:

6 years from creation or last effective date

DEA Recordkeeping:

Maintain acquisition and disposition records as required

Milestones from Draft to Operational Protocol

A sequential rollout clarifies responsibility and provides measurable milestones for compliance readiness.

01

Draft Completion

Clinical and pharmacy teams finalize content and controls.

02

Internal Review

Compliance and legal review for regulatory alignment.

03

Approval & Signatures

Authorized leaders sign and date the protocol.

04

Training and Go-Live

Staff training completed and protocol activated in operations.

eSignature Vendor Comparison for Protocol Execution

Compare common eSignature vendor characteristics relevant to controlled-substance protocols, including starting price, trial availability, and compliance features.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Practical Tips for Accurate and Efficient Protocol Management

Adopt standardized templates, clear role definitions, and digital controls to reduce errors and strengthen audits.

Standardize Templates

Use a consistent format for all protocol revisions to simplify audits and staff training.

Use Electronic Records

Store signed protocols with tamper-evident PDFs and full audit trails to protect integrity.

Train Regularly

Deliver role-based training and document completion checks during onboarding and annually.

Reconcile Frequently

Perform scheduled inventory reconciliations and document discrepancies promptly.

Real-World Examples of Protocol Use

Two concise scenarios show how organizations apply the protocol to operationalize controls and compliance.

Hospital Implementation

A tertiary hospital centralized controlled-substance ordering and inventory

Implemented daily pharmacy reconciliations
The protocol reduced discrepancies and provided a single source of truth during DEA inspections, simplifying corrective action tracking and staff accountability.

Community Clinic

A multi-site clinic adopted an electronic protocol for MAT prescribing

Added mandatory PDMP checks before each prescription
The digital workflow captured prescriber attestations and timestamps, improving oversight and reducing administrative delays.

Frequently Asked Questions About the Protocol

Answers to common operational and legal questions to help implement and maintain a compliant controlled substances protocol.

Need help? Contact support

Can the protocol be signed electronically?
Yes. Electronic signatures are generally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure the platform provides an audit trail and, for PHI, a HIPAA Business Associate Agreement.
Is notarization required for the protocol?
Not typically for operational protocols, but certain attestations or accompanying affidavits may require notarization depending on state rules; confirm with counsel.
How long must records be retained?
Retain protocol records per the longest applicable rule: HIPAA requires 6 years, IRS rules often require 3 years, and some state rules may extend retention.
What authentication should signers use?
Use at minimum email-based authentication; consider SSO or two-factor methods for privileged signers and to strengthen attribution.
Does electronic storage meet DEA requirements?
DEA accepts electronic records when they meet integrity and retrievability rules; ensure tamper-evident storage and complete audit logs.
Who to contact after suspected diversion?
Follow internal incident procedures, notify compliance leadership, and report to appropriate state agencies and law enforcement as required by state law.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now